JP2008530007A5 - - Google Patents

Download PDF

Info

Publication number
JP2008530007A5
JP2008530007A5 JP2007554134A JP2007554134A JP2008530007A5 JP 2008530007 A5 JP2008530007 A5 JP 2008530007A5 JP 2007554134 A JP2007554134 A JP 2007554134A JP 2007554134 A JP2007554134 A JP 2007554134A JP 2008530007 A5 JP2008530007 A5 JP 2008530007A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
bond
pharmaceutical composition
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007554134A
Other languages
English (en)
Japanese (ja)
Other versions
JP5227593B2 (ja
JP2008530007A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/002436 external-priority patent/WO2006083618A1/en
Publication of JP2008530007A publication Critical patent/JP2008530007A/ja
Publication of JP2008530007A5 publication Critical patent/JP2008530007A5/ja
Application granted granted Critical
Publication of JP5227593B2 publication Critical patent/JP5227593B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007554134A 2005-02-04 2006-01-24 ナンドロロン17β−カーボネート Expired - Fee Related JP5227593B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65037605P 2005-02-04 2005-02-04
US60/650,376 2005-02-04
PCT/US2006/002436 WO2006083618A1 (en) 2005-02-04 2006-01-24 NANDROLONE 17ß-CARBONATES

Publications (3)

Publication Number Publication Date
JP2008530007A JP2008530007A (ja) 2008-08-07
JP2008530007A5 true JP2008530007A5 (enExample) 2008-11-27
JP5227593B2 JP5227593B2 (ja) 2013-07-03

Family

ID=36283873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007554134A Expired - Fee Related JP5227593B2 (ja) 2005-02-04 2006-01-24 ナンドロロン17β−カーボネート

Country Status (8)

Country Link
US (1) US7820642B2 (enExample)
EP (1) EP1846434B1 (enExample)
JP (1) JP5227593B2 (enExample)
AT (1) ATE426610T1 (enExample)
AU (1) AU2006211907B2 (enExample)
CA (1) CA2596884C (enExample)
DE (1) DE602006005901D1 (enExample)
WO (1) WO2006083618A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109575098B (zh) * 2019-01-18 2021-01-01 湖南成大生物科技有限公司 诺孕美特的合成方法
CN110128529B (zh) * 2019-04-11 2023-07-07 中国农业科学院兰州畜牧与兽药研究所 一种去甲睾酮人工抗原的合成方法
WO2021252761A2 (en) * 2020-06-11 2021-12-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Monomeric and oligomeric compound embodiments as contraceptives and therapies and methods of making and using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056727A (en) * 1960-10-27 1962-10-02 Roussel Uclaf Cyclohexylcarbonates of steroids
FR1215M (fr) * 1961-03-28 1962-04-02 Roussel Uclaf S A Soc Nouveau médicament, notamment pour le traitement des troubles dus a une hyperestrogénie ou a une hypoandrogénie.
FR6576M (enExample) * 1965-10-11 1968-12-30
FR5913M (enExample) * 1965-12-02 1968-04-01
US3629244A (en) * 1966-01-21 1971-12-21 Roussel Uclaf 17beta-ethers of delta 4 9 11-gonatrienes and compositions containing them
US3523126A (en) * 1967-12-13 1970-08-04 Du Pont Testosterone and 19-nortestosterone(4'-methylbicyclo(2,2,2)octane - 1' - methyl)carbonate and selected derivatives
GB1291293A (en) 1970-05-29 1972-10-04 Du Pont Steroid carbonates and their preparation
GB1355663A (en) * 1970-06-17 1974-06-05 Theramex 19-nortestosterone 17- -p-substituted phenoxy-acetates
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
WO1993025197A1 (en) * 1992-06-12 1993-12-23 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5622944A (en) * 1992-06-12 1997-04-22 Affymax Technologies N.V. Testosterone prodrugs for improved drug delivery
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
EP1272196B1 (en) * 2000-03-31 2006-08-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
US6740646B2 (en) * 2002-01-16 2004-05-25 Biotest Laboratories, Llc Bioavailable prodrugs of androgenic steroids and related method
US20030134828A1 (en) * 2002-01-16 2003-07-17 Roberts William J. Composition and method for increasing in vivo androgen concentration
US20030134831A1 (en) * 2002-01-16 2003-07-17 Roberts William J Bioavailable prodrugs of androgenic steroids and related method

Similar Documents

Publication Publication Date Title
JP2010536766A5 (enExample)
JP2006526031A5 (enExample)
JP2009538336A5 (enExample)
JP2013507423A5 (enExample)
JP2009531376A5 (enExample)
JP2007302689A5 (enExample)
JP2009535358A5 (enExample)
JP2011227454A5 (enExample)
JP2010077141A5 (enExample)
JP2006143751A5 (enExample)
JP2013032389A5 (enExample)
JP2010523692A5 (enExample)
JP2010534247A5 (enExample)
JP2012502037A5 (enExample)
JP2020097577A5 (enExample)
JP2014505723A5 (enExample)
JP2012528813A5 (enExample)
JP2011508779A5 (enExample)
JP2010534246A5 (enExample)
JP2010507590A5 (enExample)
JP2011515406A5 (enExample)
JP2013513607A5 (enExample)
JP2011016798A5 (enExample)
JP2010510263A5 (enExample)
JP2005529175A5 (enExample)